Ratnakar Securities Pvt. Ltd.

KWALITY PHARMACEUTICALS LTD.

NSE : NABSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE1023.15-53.4 (-4.96 %)

PREV CLOSE ( ) 1076.55

OPEN PRICE ( ) 1094.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 30086

TODAY'S LOW / HIGH ( )1000.00 1095.45

52 WK LOW / HIGH ( ) 4811140

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 04-05 1983

Management Info

- Chairman Ramesh Arora - Managing Director

Registered Office

Address 6th Mile Stone,Village Nagkalan,Majitha Road,
Amritsar,
Punjab-143601

Phone 08558820862 / 63 / 9915743720

Email export@kwalitypharma.com / ramesh@kwalitypharma.com

Website www.kwalitypharma.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE

NEWS

07May Kwality Pharmaceuticals informs about
Kwality Pharmaceuticals has informed that the company has successfully c..

21Jan Kwality Pharmaceuticals informs about
Kwality Pharmaceuticals has informed that Kwality Pharmaceuticals has su..

02Jan Kwality Pharmaceuticals gets nod to st
Kwality Pharmaceuticals has secured approval from the Review Committee o..

24Dec Kwality Pharmaceuticals gets product a
Kwality Pharmaceuticals has successfully obtained product approval in So..

26Nov Kwality Pharmaceutical gets approval f
Kwality Pharmaceutical (KPL) has successfully received domestic and expo..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	144.99	398.9
Gross Profit	190.93	542.28
Operating Profit	266.64	823.64
Net Sales	1156.76	3701.97

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

RPG Life Sciences (BSE) 2417.50 (6.95%)	M.Cap ( in Cr)3998.31
TTK Healthcare (BSE) 1287.50 (3.06%)	M.Cap ( in Cr)1819.28
Dr. Reddy's Lab (BSE) 1326.40 (1.04%)	M.Cap ( in Cr)110697.51
Biocon (BSE) 348.60 (1.89%)	M.Cap ( in Cr)41852.92
Brooks Laboratories (BSE) 133.00 (4.72%)	M.Cap ( in Cr)391.78

Shareholding Pattern

	PROMOTERS	54.83%
	NON-INSTITUTION	44.86%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

KWALITY PHARMACEUTICALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES